Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance?

BMC Public Health
Mireia Alemany-PagèsAnabela Marisa Azul

Abstract

It is estimated that around 70% of Type 2 Diabetes Mellitus patients (T2DM) have Non-Alcoholic Fatty Liver Disease (NAFLD). Awareness and education are amongst the major shortcomings of the public health response to the increasing threat of NAFLD. Characterizing the specific NAFLD-related information needs of particular high-risk metabolic communities, for instance, T2DM patients, might aid in the development of evidence-based health promotion strategies, ultimately promoting NAFLD-awareness, treatment adherence and therapeutic success rates. Semi-structured interviews with T2DM patients were conducted to gain insight into their awareness of NAFLD, including its relationship with insulin resistance and T2DM. Awareness of NAFLD as a disease entity, as well as its progression to end-stage liver disease or its relationship with other metabolic conditions, including insulin resistance and T2DM was low. Surveillance behaviours were also suboptimal and perceptions on the self-management knowledge and praxis regarding lifestyle intervention components of T2DM treatment seemed detached from those of NAFLD. Our findings could inform the integration of NAFLD-related content in T2DM health promotion strategies. Rising awareness on NAFLD p...Continue Reading

References

Jan 1, 1984·Health Education Quarterly·N K Janz, M H Becker
Apr 1, 1995·Research in Nursing & Health·M Sandelowski
Feb 1, 1993·Qualitative Health Research·M J Price
Dec 1, 1995·International Journal of Nursing Studies·V E Coates, J R Boore
Apr 18, 1998·Gastroenterology·C P Day, O F James
Aug 8, 1998·International Journal of Nursing Studies·J Sim, K Sharp
Jul 23, 2002·JAMA : the Journal of the American Medical Association·Dean SchillingerAndrew B Bindman
Dec 22, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stefano BellentaniUNKNOWN Fatty Liver Italian Network
Oct 28, 2008·Social Science & Medicine·Don Nutbeam
Aug 19, 2009·Journal of Gastroenterology and Hepatology·Chi Man LeungWai Mo Hui
Mar 12, 2011·Journal of the American College of Cardiology·Christina-Maria KastoriniDemosthenes B Panagiotakos
May 24, 2011·Journal of Clinical Gastroenterology·Amit G SingalJorge A Marrero
Mar 31, 2012·Revista brasileira de enfermagem·Danielle Groleau
Dec 4, 2012·Journal of Hepatology·Elena CentisGiulio Marchesini
Jun 12, 2013·Journal of Hepatology·Fabio NascimbeniAmedeo Lonardo
Jul 12, 2013·Digestive Diseases and Sciences·Amanda C WielandKiran M Bambha
Nov 7, 2013·Administration and Policy in Mental Health·Lawrence A PalinkasKimberly Hoagwood
Nov 28, 2013·Clinics in Liver Disease·Francisco Barrera, Jacob George
Jan 21, 2014·Journal of Clinical Gastroenterology·Amanda C WielandKiran M Bambha
Feb 18, 2014·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Francesca M TrovatoGuglielmo M Trovato
Apr 16, 2014·The Lancet. Diabetes & Endocrinology·Hannele Yki-Järvinen
Feb 24, 2015·The European Journal of General Practice·Liliana LaranjoArmando B Sá
Apr 14, 2015·Gastroenterology·Eduardo Vilar-GomezManuel Romero-Gomez
Apr 29, 2015·Journal of Hepatology·Christopher D Byrne, Giovanni Targher
Dec 22, 2015·Current Gastroenterology Reports·Ala' A Abdel Jalil, Donald O Castell
Dec 29, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiMark Wymer
Jan 5, 2016·BMC Research Notes·Marluce Rodrigues GodinhoAlfredo Chaoubah
Mar 17, 2016·Annual Review of Pathology·Timothy HardyChristopher P Day
Apr 12, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver (EASL)UNKNOWN European Association for the Study of Obesity (EASO)
Apr 20, 2016·Journal of Hepatology·Sven M FrancqueWilhelmus J Kwanten
May 10, 2016·World Journal of Gastroenterology : WJG·Liat MlynarskyShira Zelber-Sagi
Mar 30, 2017·World Journal of Gastroenterology : WJG·Shira Zelber-SagiOren Shibolet
May 27, 2017·Journal of Hepatology·Manuel Romero-GómezMichael Trenell
Aug 13, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Chris EstesArun J Sanyal
Nov 13, 2017·Acta Diabetologica·Rosario CarusoDavide Ausili
Dec 6, 2017·The European Journal of General Practice·Irene Korstjens, Albine Moser
Dec 17, 2017·Journal of Gastroenterology·Yoshio Sumida, Masashi Yoneda
Apr 24, 2018·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Zobair M Younossi
May 20, 2018·Journal of Hepatology·Laura PimpinUNKNOWN EASL HEPAHEALTH Steering Committee
Jul 4, 2018·Nature Medicine·Scott L FriedmanArun J Sanyal
Jul 10, 2018·Journal of Patient-reported Outcomes·Tessa Kennedy-MartinEmily Freeman
Aug 26, 2018·Gastroenterology·Fasiha KanwalHashem B El-Serag

❮ Previous
Next ❯

Citations

May 8, 2021·The Lancet. Gastroenterology & Hepatology·Giovanni TargherChristopher D Byrne
Jun 27, 2021·Nature Reviews. Gastroenterology & Hepatology·Jeffrey V LazarusJörn M Schattenberg
Aug 15, 2021·European Journal of Clinical Investigation·Adriana FontesAnabela Marisa Azul

❮ Previous
Next ❯

Software Mentioned

MAXQDA
VERBI

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved